Niels Moya

French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry

Benoît Ferment, Jérôme Lambert, Denis Caillot et al. · British Journal of Haematology · 2024 · 28 citations · Full text

Medicine, Immunology, Oncology +17

Response to pneumococcal vaccination in multiple myeloma

Loïc Renaud, Susanna Schraen, Guillemette Fouquet et al. · Cancer Medicine · 2019 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma

Guillemette Fouquet, Stéphanie Guidez, Valentine Richez et al. · Oncotarget · 2018 · 16 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine

Antoine Machet, Caroline Poudou, Cécile Tomowiak et al. · Blood Advances · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +14